Breast Cancer Research Info

Breast cancer is regarded as as a killer disease and it is known to be the number one cause of cancer death among women. According to American cancer society, about 1.3 million new breast cancer cases are diagnosed on an annual basis which includes 465,000 deaths. In order to productively tackle this disturbing disease, we must push revolutionary scientists to study cancer at its most basic stage. In other words, breast cancer investigation work must be performed at its molecular level. Also, besides the governments, private organizations must provide flexible funding to scientists who will be conducting breast cancer research work.

Proper financial support of breast cancer study projects; can not only lead to better prevention strategies but it can also assist towards earlier diagnostic techniques and new anticancer medication and treatments.

Not so long ago, scientists who are working towards breast cancer research project, have created and successfully tested a breast cancer vaccine which is likely to cure women with treatment – resistant HER2 – positive breast cancer and thus be able to prevent cancer remission. Breast cancer researchers look forward to use HER2 DNA vaccines for cancer-free women, in order to prevent early development of these tumours. At present therapies such as trastuzumab and lapatimib are utilized in treating breast cancer patients. However, it was recently observed that a big group of patients develop a resistance towards trastuzumab and lapatimib. HER2 receptors are known to promote a specifically aggressive kind of tumour that affects about thirty percent of breast cancer patients. The new breast cancer vaccine is created by the body’s own cells. It delivers a cancer combating gene into cells, which subsequently form immune system proteins and also cancer ? fighting cells.

According to the primary researcher Wei – Zen Wei, a professor of immunology and microbiology at the Karmanos Cancer Institute, the vaccine is created by using so – called naked DNA from genes that produces the HER2 receptor. This DNA is put along with an immune stimulant. The process involved in the making of the vaccine, is called as electro oration.

In this process, pulses of electricity were used in order to inject the vaccine into the leg muscles in mice. The genes moved towards the cells, which then produced HER2 receptors that led to activation of antibodies and immune cells called Killer T cells.